Home » Topics » Regulatory » EMA

EMA
RSS

EMA committee recommends change to marketing authorization terms for Feraccru

Feb. 26, 2018

BioCryst's Alpivab recommended for approval in E.U. for uncomplicated influenza

Feb. 26, 2018

Amglidia recommended for E.U. approval for neonatal diabetes

Feb. 26, 2018

EMA committee recommends approval of Mylotarg and Bosulif in E.U.

Feb. 26, 2018

EMA committee hands down positive opinion for Kineret in Still's disease

Feb. 26, 2018

Xgeva recommended for E.U. approval to prevent skeletal-related events in multiple myeloma

Feb. 26, 2018

EMA committee hands down negative opinion on Puma's neratinib

Feb. 26, 2018

EMA committee recommends against expanding use of Sutent in adults at high risk of recurrent RCC

Feb. 26, 2018

CHMP adopts positive opinion for Lynparza tablets in platinum-sensitive relapsed ovarian cancer

Feb. 26, 2018

EMA committee communicates positive trend vote for rucaparib

Feb. 22, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026